No abstract available.
Drug Therapy* ; Ovarian Neoplasms*

No abstract available.
Drug Therapy* ; Ovarian Neoplasms*

No abstract available.
Cisplatin* ; Drug Therapy* ; Ovarian Neoplasms*

No abstract available.
Cisplatin* ; Drug Therapy* ; Ovarian Neoplasms*

No abstract available
Cell Line* ; Drug Therapy ; Humans* ; Ovarian Neoplasms*

No abstract available.
Carboplatin* ; Drug Therapy* ; Ovarian Neoplasms* ; Paclitaxel*

Cerebral metastses secondary to primary epithelial ovarian carcinoma are unusual. The incidence was estimated under 1%, but some authors reported higher incidence than previously reported data. Recently, we experienced a case of cerebral metastasis secondary to primary epithelial ovarian cancer. We present this case with review of brief related literatures.
Drug Therapy* ; Incidence ; Neoplasm Metastasis ; Ovarian Neoplasms

No abstract available.
Drug Therapy ; Japan ; Joints ; Ovarian Neoplasms

Surgery continues to be an important option in the management of recurrent gynecologic malignancies. As a single modality, it can be the sole curative treatment for a selected group of patients with localized recurrent malignancy and contributes to the management of patients with more disseminated recurrent malignancy as part of multimodal treatment. The use of exenterative surgery for localized recurrence has been extended, and complications have been minimized. Our understanding of the role of cytoreduction in disseminated recurrence has increased, but care must be taken in order to maximize the benefit of cytoreduction and minimize morbidity until the evidences are more clarified in prospective randomized trial. Morbidity related to radical surgery can be reduced without compromising patient cure by individualizing surgery. Moreover, newer reconstructive techniques can improve quality of life. Sometimes, surgery can be performed with relatively simple procedures, such as wide local excision. However, for more disseminated cancers, such as metastatic ovarian cancer, surgery can be very complex, requiring resection of several non-gynecological organs. Therefore extensive surgical training and experience is needed to successfully manage patients with these challenging conditions, and this has resulted in the development of the subspecialty of gynecological oncology. A brief update on the role of surgery in the management of recurrent gynecologic malignancies is presented in this article.
Combined Modality Therapy ; Humans ; Ovarian Neoplasms ; Quality of Life ; Recurrence

Steroid cell tumors, not otherwise specified, are infrequently encountered ovarian neoplasms, which constitute <0.1% of all ovarian tumors. Most of these tumors are unilateral, and almost one-third of all cases are reportedly malignant. However, because most of these tumors are diagnosed in the early stage, and do not recur or metastasize, little is known about their response to therapies such as chemotherapy or radiation. Here, we present a rare case of recurrent steroid cell tumor, not otherwise specified that showed a complete response after debulking surgery, radiofrequency ablation, and adjuvant chemotherapy.
Catheter Ablation* ; Chemotherapy, Adjuvant* ; Drug Therapy ; Ovarian Neoplasms